Financhill
Back

Intellia Therapeutics Vs. Progress Software Industry Stock Comparison

Sell
29

NTLA
Intellia Therapeutics

Last Price:
$12.07
Seasonality Move:
-9.64%
Sell
35

PRGS
Progress Software

Last Price:
$47.45
Seasonality Move:
4.9%
Sell
29
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $12.06. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Progress Software (PRGS) is a Sell

Is Progress Software a Buy, Sell or Hold?

  • The current Progress Software [PRGS] share price is $47.47. The Score for PRGS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PRGS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $12.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight selling pressure.

PRGS Stock Price Chart

What is Progress Software's stock price today?

  • The Progress Software share price today is $47.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRGS is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.3 Buy
Relative Strength Index (14 RSI): 65.89 Buy
Chaikin Money Flow: -1627212 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.12 - 11.58) Buy
Bollinger Bands (100): (7.5 - 10.36) Buy

PRGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 13.44 Buy
Relative Strength Index (14 RSI): 22.89 Sell
Chaikin Money Flow: -649163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.33 - 63.45) Sell
Bollinger Bands (100): (53.53 - 62.49) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.89 Buy
20-day SMA: 10.7 Buy
50-day SMA: 9.34 Buy
200-day SMA: 11.51 Buy
8-day EMA: 10.63 Buy
20-day EMA: 7.02 Buy
50-day EMA: 3.57 Buy
200-day EMA: 1.02 Buy

PRGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.12 Sell
20-day SMA: 55.33 Sell
50-day SMA: 59.64 Sell
200-day SMA: 61.13 Sell
8-day EMA: 43.61 Buy
20-day EMA: 29.18 Buy
50-day EMA: 14.93 Buy
200-day EMA: 4.26 Buy

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.13 per share, and an increase next year of $0.30 per share.

Progress Software Earnings Growth & PRGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.11 per share, an increase this year of $0.53 per share, and an increase next year of $0.32 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Progress Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):